We are live on
!
Find out more
Voloridge Investment Management Portfolio holdings
AUM
$25B
1-Year Est. Return
28.08%
This Fund
S&P 500
This Quarter
Est. Return
+24.52%
1 Year Est. Return
+28.08%
3 Year Est. Return
+85.2%
5 Year Est. Return
+73.43%
10 Year Est. Return
+582.16%
AUM
$11.9B
AUM Growth
-$101M
(-0.84%)
Cap. Flow
-$1.72B
Cap. Flow
% of AUM
-14.47%
Top 10 Holdings %
Top 10 Hldgs %
16.8%
Holding
1,692
New
482
Increased
315
Reduced
482
Closed
413
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$242M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$187M |
| 3 |
AstraZeneca
AZN
|
+$163M |
| 4 |
Lockheed Martin
LMT
|
+$162M |
| 5 |
S&P Global
SPGI
|
+$125M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$234M |
| 2 |
Johnson & Johnson
JNJ
|
+$185M |
| 3 |
Mercado Libre
MELI
|
+$136M |
| 4 |
Procter & Gamble
PG
|
+$128M |
| 5 |
Shopify
SHOP
|
+$126M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.38% |
| 2 | Healthcare | 15.54% |
| 3 | Consumer Discretionary | 12.1% |
| 4 | Industrials | 11.12% |
| 5 | Communication Services | 10.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Abercrombie & Fitch
ANF
$4.84B
| $8.82M | 0.07% |
433,313
+71,493
| +20% | +$1.31M |
|
302
Highwoods Properties
HIW
$3.51B
| $8.81M | 0.07% |
222,421
+155,821
| +234% | +$5.63M |
|
303
Zimmer Biomet
ZBH
$19B
| $8.8M | 0.07% |
+58,841
| New | +$8.31M |
|
304
Genpact
G
$5.78B
| $8.8M | 0.07% |
212,698
+163,437
| +332% | +$6.46M |
|
305
iQIYI
IQ
$1.31B
| $8.79M | 0.07% |
+502,665
| New | +$11.3M |
|
306
Microchip Technology
MCHP
$42.2B
| $8.74M | 0.07% |
+126,618
| New | +$7.88M |
|
307
Bloom Energy
BE
$69.6B
| $8.73M | 0.07% |
304,465
+150,327
| +98% | +$3.21M |
|
308
Halozyme
HALO
$11.4B
| $8.72M | 0.07% |
204,136
-169,237
| -45% | -$6.08M |
|
309
Marriott International
MAR
$91.9B
| $8.7M | 0.07% |
65,943
-31,599
| -32% | -$3.61M |
|
310
Arvinas
ARVN
$589M
| $8.66M | 0.07% |
102,016
+86,956
| +577% | +$3M |
|
311
Cintas
CTAS
$80.3B
| $8.66M | 0.07% |
98,024
+79,832
| +439% | +$6.93M |
|
312
Newmont
NEM
$120B
| $8.64M | 0.07% |
144,197
-780,011
| -84% | -$48.1M |
|
313
Equinix
EQIX
$106B
| $8.63M | 0.07% |
12,082
+9,385
| +348% | +$6.99M |
|
|
VMW
314
DELISTED
VMware, Inc
VMW
| $8.59M | 0.07% |
61,228
+33,093
| +118% | +$4.74M |
|
315
LendingTree
TREE
$461M
| $8.52M | 0.07% |
+31,124
| New | +$9.25M |
|
316
Ameren
AEE
$30.2B
| $8.49M | 0.07% |
+108,736
| New | +$8.71M |
|
317
Visteon
VC
$2.86B
| $8.48M | 0.07% |
67,543
+57,584
| +578% | +$6.07M |
|
318
BridgeBio Pharma
BBIO
$15.9B
| $8.46M | 0.07% |
119,021
-34,854
| -23% | -$1.68M |
|
319
Wabtec
WAB
$50.3B
| $8.42M | 0.07% |
+115,007
| New | +$7.87M |
|
|
HOME
320
DELISTED
At Home Group Inc.
HOME
| $8.41M | 0.07% |
544,093
-42,032
| -7% | -$732K |
|
321
LPL Financial
LPLA
$29.5B
| $8.41M | 0.07% |
80,697
+56,323
| +231% | +$5.06M |
|
322
MP Materials
MP
$9.91B
| $8.4M | 0.07% |
+261,097
| New | +$5.05M |
|
|
LKFT
323
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.84B
| $8.39M | 0.07% |
84,802
+73,460
| +648% | +$8.98M |
|
|
LTHM
324
DELISTED
Livent Corporation
LTHM
| $8.39M | 0.07% |
+445,474
| New | +$6.21M |
|
325
Otis Worldwide
OTIS
$27.8B
| $8.39M | 0.07% |
+124,164
| New | +$8.05M |
|
Similar funds
VAI
JG
OAG
Voloridge Investment Management's Q4 2020 Portfolio in Review
As of Q4 2020, Voloridge Investment Management held 1,692 positions worth $11.9B, down 0.84% from $12B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Voloridge Investment Management withdrew a net $1.72B in Q4 2020, closing 413 positions and reducing 482 holdings. Its most notable exit was Wells Fargo, an estimated $111M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Voloridge Investment Management opened a new position in AstraZeneca worth $154M.
- Voloridge Investment Management's largest Q4 2020 buy was AstraZeneca: 1,542,881 shares worth $154M.
- Voloridge Investment Management added most to Microsoft in Q4 2020, an estimated $242M increase.
- Voloridge Investment Management's biggest Q4 2020 reduction was Citigroup, cutting an estimated $234M.
- Voloridge Investment Management fully exited Wells Fargo in Q4 2020, selling an estimated $111M.
- Voloridge Investment Management's ten largest holdings make up 17% of its $11.9B portfolio in Q4 2020.
- Voloridge Investment Management opened 482 new positions and closed 413 in Q4 2020.
- Voloridge Investment Management's portfolio value fell 0.84% quarter-over-quarter to $11.9B.
Based on Voloridge Investment Management's 13F filing for Q4 2020, filed 16 Feb 2021.